BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12712482)

  • 1. Neurologic complications of bladder carcinoma: a review of 359 cases.
    Anderson TS; Regine WF; Kryscio R; Patchell RA
    Cancer; 2003 May; 97(9):2267-72. PubMed ID: 12712482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of schistosomiasis on urinary bladder cancer in the southern province of Saudi Arabia: review of 60 cases.
    Khurana P; Morad N; Khan AR; Shetty S; Ibrahim A; Patil K
    J Trop Med Hyg; 1992 Apr; 95(2):149-51. PubMed ID: 1560487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Statistical survey of metastasis of bladder tumors--from the annual of pathological autopsy cases in Japan].
    Pak K; Kim CJ; Ishida A; Shirasu A; Tomoyoshi T
    Hinyokika Kiyo; 1987 Nov; 33(11):1835-9. PubMed ID: 3328508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small cell carcinoma of the bladder: a contemporary clinicopathological study of 51 cases.
    Abrahams NA; Moran C; Reyes AO; Siefker-Radtke A; Ayala AG
    Histopathology; 2005 Jan; 46(1):57-63. PubMed ID: 15656887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases.
    Lagwinski N; Thomas A; Stephenson AJ; Campbell S; Hoschar AP; El-Gabry E; Dreicer R; Hansel DE
    Am J Surg Pathol; 2007 Dec; 31(12):1777-87. PubMed ID: 18043032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
    Cai T; Nesi G; Boddi V; Mazzoli S; Dal Canto M; Bartoletti R
    Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients.
    Cheng L; Pan CX; Yang XJ; Lopez-Beltran A; MacLennan GT; Lin H; Kuzel TM; Papavero V; Tretiakova M; Nigro K; Koch MO; Eble JN
    Cancer; 2004 Sep; 101(5):957-62. PubMed ID: 15329903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma.
    Mizutani Y; Matsubara H; Yamamoto K; Nan Li Y; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
    Cancer; 2004 Oct; 101(8):1794-802. PubMed ID: 15386310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoma in a bladder diverticulum: presentation and treatment outcome.
    Golijanin D; Yossepowitch O; Beck SD; Sogani P; Dalbagni G
    J Urol; 2003 Nov; 170(5):1761-4. PubMed ID: 14532771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurologic complications of ovarian carcinoma.
    Abrey LE; Dalmau JO
    Cancer; 1999 Jan; 85(1):127-33. PubMed ID: 9921984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder.
    May M; Nitzke T; Helke C; Vogler H; Hoschke B
    Scand J Urol Nephrol; 2004; 38(3):231-5. PubMed ID: 15204377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphologic diversity of malignant neoplasms arising in preexisting spiradenoma, cylindroma, and spiradenocylindroma based on the study of 24 cases, sporadic or occurring in the setting of Brooke-Spiegler syndrome.
    Kazakov DV; Zelger B; Rütten A; Vazmitel M; Spagnolo DV; Kacerovska D; Vanecek T; Grossmann P; Sima R; Grayson W; Calonje E; Koren J; Mukensnabl P; Danis D; Michal M
    Am J Surg Pathol; 2009 May; 33(5):705-19. PubMed ID: 19194280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer.
    Divrik RT; Sahin A; Altok M; Unlü N; Zorlu F
    J Urol; 2007 Sep; 178(3 Pt 1):802-6; discussion 806. PubMed ID: 17632171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experience.
    Kassouf W; Spiess PE; Siefker-Radtke A; Swanson D; Grossman HB; Kamat AM; Munsell MF; Guo CC; Czerniak BA; Dinney CP
    Cancer; 2007 Aug; 110(4):764-9. PubMed ID: 17614317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
    David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
    Chou EC; Lin AT; Chen KK; Chang LS
    Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.